Pasithea Therapeutics Corp. (KTTA)
USD 2.54
(-4.51%)
USD 2.54
(-4.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -13.42 Million | -14.56 Million | -3.17 Million | -38.68 Thousand |
| Net Income | -15.5 Million | -13.93 Million | -2.17 Million | -40.98 Thousand |
| Depreciation & Amortization | 648.45 Thousand | 32.37 Thousand | 1379.00 | - |
| Deferred income taxes | -1.07 Billion | - | -2.33 Million | - |
| Stock-based compensation | 592.26 Thousand | 835.06 Thousand | 471.25 Thousand | - |
| Change in working capital | 1.57 Million | -138.43 Thousand | 111.23 Thousand | 2295.00 |
| Other non-cash items | 1.07 Billion | -1.07 Million | 750 Thousand | 9904.00 |
| Investing Cash Flow | 399 Thousand | -2.06 Million | -21.5 Thousand | - |
| Investments in PPE | -34.3 Thousand | -2.13 Million | -21.5 Thousand | - |
| Acquisitions | 109.5 Thousand | 77.06 Thousand | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | 323.8 Thousand | -626.89 Thousand | - | - |
| Financing Cash Flow | -3.72 Million | -3.2 Million | 55.92 Million | 282.33 Thousand |
| Debt repayment | -392.35 Thousand | - | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | -3.72 Million | -3.2 Million | - | - |
| Common Stock Issuance | - | - | 50.23 Million | 282.33 Thousand |
| Other Financing Activities | -611.27 Thousand | -3.2 Million | 5.69 Million | 423.5 Thousand |
| Accounts receivables | - | - | - | - |
| Accounts payables | 1.07 Billion | 831.64 Million | 440.67 Thousand | - |
| Inventory | - | - | - | - |
| Other working capital | -1.06 Billion | -831.77 Million | -329.44 Thousand | 2295.00 |
| Cash at beginning of period | 33.08 Million | 52.96 Million | 243.65 Thousand | - |
| Cash at end of period | 16.33 Million | 33.14 Million | 52.96 Million | 243.65 Thousand |
| Capital Expenditure | -34.3 Thousand | -2.13 Million | -21.5 Thousand | - |
| Effect of forex changes on cash | -3991.00 | 9900.00 | -10.56 Thousand | - |
| Net cash flow / Change in cash | -16.75 Million | -19.81 Million | 52.72 Million | 243.65 Thousand |
| Free Cash Flow | -13.45 Million | -16.7 Million | -3.19 Million | -38.68 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.86 Million | -3.86 Million | -15.5 Million | -5.03 Million | -3.61 Million | -3.59 Million |
| Depreciation & Amortization | 162.25 Thousand | 162.25 Thousand | 648.45 Thousand | 162.22 Thousand | 162.25 Thousand | 162.25 Thousand |
| Deferred income taxes | - | - | -1.07 Billion | -394.38 Thousand | 538.13 Thousand | -578.16 Thousand |
| Stock-based compensation | 160.95 Thousand | 346.47 Thousand | 592.26 Thousand | 69.94 Thousand | 126.67 Thousand | 218.63 Thousand |
| Change in working capital | -531.44 Thousand | -942.26 Thousand | 1.57 Million | 1.45 Million | 129.85 Thousand | 315.04 Thousand |
| Other non-cash items | 521.08 Thousand | 644.27 Thousand | 1.07 Billion | 429.91 Thousand | 960.00 | 960.00 |
| Investing Cash Flow | - | - | 399 Thousand | 54.53 Thousand | 50.15 Thousand | 344.01 Thousand |
| Investments in PPE | - | - | -34.3 Thousand | 36.00 | 22.65 Thousand | -3108.00 |
| Acquisitions | - | - | 109.5 Thousand | 54.5 Thousand | 27.5 Thousand | 27.5 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 323.8 Thousand | 54.5 Thousand | 27.5 Thousand | 319.61 Thousand |
| Financing Cash Flow | - | - | -3.72 Million | -16.89 Thousand | -4.45 Million | -130.76 Thousand |
| Debt repayment | - | - | -392.35 Thousand | -392.35 Thousand | -133.33 Thousand | -130.76 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -3.72 Million | -3.72 Billion | -3.72 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 986.73 Thousand | -594.38 Thousand | -134.95 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | -118.36 Million | 1.07 Billion | 1.1 Billion | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -531.44 Thousand | -942.26 Thousand | -1.06 Billion | 1.45 Million | 129.85 Thousand | 315.04 Thousand |
| Cash at beginning of period | 12 Million | 16.33 Million | 33.08 Million | 19.58 Million | 26.64 Million | 29.91 Million |
| Cash at end of period | 7.96 Million | 12 Million | 16.33 Million | 16.33 Million | 19.58 Million | 26.64 Million |
| Capital Expenditure | - | - | -34.3 Thousand | 36.00 | 22.65 Thousand | -3108.00 |
| Effect of forex changes on cash | -2912.00 | -620.00 | -3991.00 | 3065.00 | -4256.00 | -317.00 |
| Net cash flow / Change in cash | -4.04 Million | -4.32 Million | -16.75 Million | -3.25 Million | -7.06 Million | -3.26 Million |
| Free Cash Flow | -4.03 Million | -4.32 Million | -13.45 Million | -3.31 Million | -2.63 Million | -3.48 Million |
6333
2404
CL
2185
600483
002383